LIQUID BIOPSY LOOKS TO THE FUTURE
When innovation made in Italy is combined, precision medicine goes beyond borders. Milan - Siena - San Francisco - January 15, 2020 LCM GENECT, an innovative molecular diagnostics enterprise, has formalized the agreement with EXOSOMICS, a leading company in research in the field of exosomes and in the development of solutions for pan-tumor screening and molecular oncological diagnostics based on analysis of exosomes. LCM GENECT is the sole...
Read More